• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA Clears Emerging AI Software for Brain MRI

News
Article

The artificial intelligence (AI)-powered software VUNO Med-DeepBrain reportedly automates brain MRI segmentation and provides access to volumetric data on over 100 regions of the brain.

Offering a potentially time-saving antidote to manual identification and quantification of brain structures on magnetic resonance imaging (MRI), the VUNO Med®-DeepBrain® artificial intelligence (AI) software has garnered 510(k) clearance from the Food and Drug Administration (FDA).

VUNO, the developer of the software, said that in addition to white matter hyperintensity and cortical thickness assessments, VUNO Med-DeepBrain offers access to volumetric information on over 100 brain regions.

Offering quantifiable brain data in a customizable report, VUNO Med-DeepBrain may also facilitate earlier diagnosis in cases involving dementia or other neurodegenerative conditions. In study findings presented at the recent Alzheimer’s Association International Conference (AAIC), researchers found that VUNO Med-DeepBrain can predict amyloid positivity in patients with subjective cognitive decline, according to VUNO.

“With this product, we will make every effort to help improve the declining quality of life experienced by many dementia patients,” added Yeha Lee, the CEO of VUNO.

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
Study: CT-Based AI Offers Enhanced Sensitivity and Reduced Segmentation Time for Lung Tumors

Study: CT-Based AI Offers Enhanced Sensitivity and Reduced Segmentation Time for Lung Tumors

Jeff Hall
January 21st 2025
Article

Emerging research suggests that a deep learning model may offer 92 percent sensitivity in lung tumor detection on CT scans and up to a 59 percent reduction in tumor segmentation time.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

Jeff Hall
January 20th 2025
Article

In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

FDA Clears Brain MRI-Based Software for Assessing Cortical Disarray Measurement

FDA Clears Brain MRI-Based Software for Assessing Cortical Disarray Measurement

Jeff Hall
January 16th 2025
Article

The CDM Insights software, which can be utilized with scans from 1.5T and 3T MRI, reportedly provides new measurements of cortical thickness and brain microstructure.

Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?

Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?

Jeff Hall
January 14th 2025
Article

Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.

© 2025 MJH Life Sciences

All rights reserved.